Skip to main content
Clinical Trials/NCT05660161
NCT05660161
Recruiting
Not Applicable

A Pilot Study to Evaluate the Functional Outcome of Nanofractures for the Treatment of Cartilage Lesions

Ente Ospedaliero Cantonale, Bellinzona1 site in 1 country20 target enrollmentMarch 2, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cartilage Damage
Sponsor
Ente Ospedaliero Cantonale, Bellinzona
Enrollment
20
Locations
1
Primary Endpoint
Functional outcomes measured by International Knee Documentation Committee subjective score
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

Articular cartilage lesions, with their inherent limited healing potential, remain a challenging problem for orthopaedic surgeons. Various techniques, both palliative and reparative, have been used to treat this injury with variable success rates. If not adequately treated, they may even lead to the development of early-onset osteoarthritis. Among all the available techniques, microfractures are used in restoring the cartilage tissue, especially in the deep and extended lesions.

More recently, the need for minor bone trauma with still adequate bleeding resulted in the development of nanofractures. Nanofracturing means creating perforations with a smaller diameter that go deeper into the bone while damaging it less. This is supposed to reduce the injury to the subchondral bone and increase the amount of bone marrow-derived mesenchymal stromal cells at the bone surface.

Thus, the aim of this pilot study is to evaluate the efficacy of nanofractures for the treatment of cartilage lesions of the knee, specifically focusing on the chondral healing that will be addressed with magnetic resonance imaging.

Registry
clinicaltrials.gov
Start Date
March 2, 2023
End Date
January 1, 2027
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ente Ospedaliero Cantonale, Bellinzona
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with cartilage lesions of the knee scheduled for surgery
  • Age 16-50
  • BMI between 18.5 and 30 points
  • Ability to give informed consent

Exclusion Criteria

  • Uncorrected knee instability
  • Meniscectomy \> 50%
  • Uncorrected knee misalignment
  • Uncontrolled metabolic diseases
  • Inability to give informed consent

Outcomes

Primary Outcomes

Functional outcomes measured by International Knee Documentation Committee subjective score

Time Frame: 12 months

The IKDC subjective score is a patient-completed tool to evaluate knee function. It contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Secondary Outcomes

  • Functional outcomes measured by International Knee Documentation Committee subjective score(6 months, 24 months)
  • Activity level measured by Tegner score(6 months, 12 months, 24 months)
  • Knee pain on the Visual Analogic Scale(6 months, 12 months, 24 months)
  • Activity level measured by Knee injury and Osteoarthritis Outcome Score(6 months, 12 months, 24 months)
  • Cartilage Repair Tissue measured by Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) 2.0 score(12 months)

Study Sites (1)

Loading locations...

Similar Trials